Primary antiphospholipid antibody syndrome masquerading as progressive supranuclear palsy

Lupus

Volumn 12, Issue 1, 2003, Pages 67-69

  Reitblat, T ^a   Polishchuk, I ^a   Dorodnikov, E ^a   Aladjem, Z ^a   Turiansky, L ^a   Zamir, D ^a   Kahana, E ^a  

^a BARZILAI MEDICAL CENTER   (Israel)

Author keywords

Anticardiolipin antibody; Antiphospholipid antibody syndrome; Lupus anticoagulant; Progressive supranuclear palsy

Indexed keywords

CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BRAIN SCINTISCANNING; CASE REPORT; CLINICAL FEATURE; HUMAN; LIVEDO RETICULARIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; THROMBOCYTOPENIA; VASCULAR DISEASE;

ANTIBODIES, ANTICARDIOLIPIN; ANTIPHOSPHOLIPID SYNDROME; DIAGNOSIS, DIFFERENTIAL; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 0037269782     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203303lu242CR     Document Type: Article

References (10)

1. Wilson WA, Gharavi AE, Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42(7): 1309-1311.
2. Victor M, Ropper AH. Progressive supranuclear palsy. In Adams, Victor M (eds). Principles of Neurology, 7th edn. McGraw-Hill: New York, 2001, pp 1138-1140.
3. Dubinski RM, Jankovic J. Progressive supranuclear palsy and multi-infarct state. Neurology 1987; 37(4): 570-576.
4. Steele JC, Richardson J, Olszewski J. Progressive supranuclear palsy: a heterogenous degeneration involving the brainstem, basal ganglia and cerebellum with vertical gaze palsy and pseudobulbar palsy, nuchal dystonia, and dementia. Arch Neurol 1964; 2: 473-486.
5. Brey RL, Hart RG, Sherman DG, Tegeler CH. Antiphospholipid antibodies and cerebral ischemia in young people. Neurology 1990; 40: 1190-1196.
6. Tietjen GE, Day M, Norris L et al. Role of anticardiolipin antibodies in young persons with migraine and transient focal neurologic events: a prospective study. Neurology 1998; 50(5): 1433-1440.
7. Cervera R, Asherson RA, Font J et al. Chorea in the antiphopholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature. Medicine (Balt) 1997; 76(3): 203-212.
8. Coull BM, Bourdette DN, Goodnight SH, Jr, Briley DP, Hart R. Multiple cerebral infarctions and dementia associated with anticardiolipin antibodies. Stroke 1987; 18(6): 1107-1112.
9. Levine SR, Brey RL. Neurological aspects of antiphospholipid antibody syndrome. Lupus 1996; 5: 347-353.
10. Mochizuki H, Okano M, Nagata N, Kamakura K. [A case of Sjogren's syndrome with a high titer of anticardiolipin antibody that developed as parkinsonism.] Rinsho Shinkeigaku 1997; 37(1): 57-59. (In Japanese.)